Raptor Pharmaceuticals Corp. (”Raptor” or the “Company”) (OTC Bulletin Board: RPTP), declared constructive results in its Phase IIa think of test 4-methylpyrazole (”4-MP”) in subjects with ALDH2 deficiency, or beverage intolerance, as the initial utilization initiate of its Convivia(TM) program. Convivia(TM) is Raptor’s copyrighted test compound of 4-MP fashioned to turn systemic aldehyde danger and attendant symptoms in ALDH2 nonstandard persons mass beverage consumption.

Tags: Alcohol